v-crk sarcoma virus CT10 oncogene homolog (avian)-like (CRKL); integrin β1 BriefCommunication Pages: 87 - 87
Leucine-rich repeat-containing G protein–coupled receptor 5 (LGR5; GPR49); adenomatous polyposis coli (APC) BriefCommunication Pages: 88 - 88
Prominin 1 (PROM1; CD133); β-catenin (CTNNB1); leucine-rich repeat-containing G protein–coupled receptor 5 (LGR5; GPR49) BriefCommunication Pages: 89 - 89
CD226 (DNAM-1); killer cell lectin-like receptor subfamily K, member 1 (KLRK1; NKG2D) BriefCommunication Pages: 91 - 91
Chemokine (C-C motif) ligand 5 (CCL5; RANTES); platelet factor 4 (CXCL4; PF4) BriefCommunication Pages: 93 - 93
von Hippel–Lindau tumor suppressor (VHL); hypoxia-inducible factor 1 (HIF1A; HIF1) BriefCommunication Pages: 94 - 94
Cryptosporidium parvum nonspecific polyprenyl pyrophosphate synthase (CpNPPPS) BriefCommunication Pages: 99 - 99
Eukaryotic translation initiation factor 2A, 65kDa (EIF2A); β-site APP cleaving enzyme-1 (BACE1) BriefCommunication Pages: 104 - 104
Calcium channel, voltage-dependent, P/Q type, α1A subunit (CACNA1A) BriefCommunication Pages: 106 - 106
Glucagon-like peptide-1 (GCG; GLP-1); GLP-1 receptor (GLP1R; GLP-1R) BriefCommunication Pages: 111 - 111
Integrinα3 (ITGA3; VLA3); β-catenin (CTNNB1); SMAD family member 2 (SMAD2) BriefCommunication Pages: 113 - 113
Sequential long- and short-read transcriptome sequencing for gene fusion detection BriefCommunication Pages: 116 - 116
Tandem array-based expression screens to identify microRNA targets BriefCommunication Pages: 117 - 117
Induced pluripotent stem (iPS) cell model of spinal muscular atrophy (SMA) BriefCommunication Pages: 118 - 118
Magnetic nanoparticle (MNP)-assisted gene and cell replacement therapies BriefCommunication Pages: 119 - 119
Transferrin receptor (TFRC)-targeted lipid nanoparticles (TfLNs) for delivery of antisense oligonucleotides BriefCommunication Pages: 120 - 120
Short antisense oligonucleotides (ASOs) with lower toxicity and increased potency BriefCommunication Pages: 121 - 121
